Xerostomia, thirst, sodium gradient and inter-dialytic weight gain in hemodialysis diabetic vs. non-diabetic patients by Bruzda-Zwiech, Agnieszka et al.
Med Oral Patol Oral Cir Bucal. 2018 Jul 1;23 (4):e406-12.                                                                                    Xerostomia, sodium gradient and IWG in HD diabetic vs. non-diabetic patients  
e406
Journal section: Medically compromised patients in Dentistry
Publication Types: Research
Xerostomia, thirst, sodium gradient and inter-dialytic weight 
gain in hemodialysis diabetic vs. non-diabetic patients
Agnieszka Bruzda-Zwiech 1, Joanna Szczepańska 1, Rafał Zwiech 2 
1 Department of Pediatric Dentistry, Medical University of Lodz, Poland, 92-213 Lodz, Pomorska 251 
2 Dialysis Department, Norbert Barlicki Memorial Teaching Hospital No. 1 90-153 Lodz, Poland, Kopcinskiego 22
Correspondence:
Department of Pediatric Dentistry
Medical University of Lodz, Poland





Background: In hemodialysis (HD) patients, xerostomia and hyposalivation may intensify sensations of thirst, and 
contribute to the intake of fluids and excessive inter-dialytic weight gain (IWG). Since IWG is regarded to be high-
er in diabetic patients than in non-diabetics HD enhancing their mortality, it is crucial to define plausible under-
lying causes. Therefore, the study investigates factors contributing to the increased IWG in diabetic HD patients.
Material and Methods: The study included 97 HD patients (38 diabetics) receiving hemodialysis. All partici-
pants completed surveys comprising the Dialysis Thirst Inventory (DTI) and Xerostomia Inventory. Unstimulated 
whole saliva flow rate (USWFR) was measured, with USWFR below 0.1 mL/min being regarded as hyposaliva-
tion. Additionally, pre- and post-dialysis serum sodium concentration, sodium gradient and IWG were assessed. 
In diabetic HD patients, hemoglobin A1c (HbA1c) level was measured.
Results: Significantly higher scores were found in diabetic than non-diabetic HD patients with regard to DTI 
(21.2±7.7 vs. 17.1±6.2: Z=2.44, p=0.03) and xerostomia (40.5±6.1 vs. 29.9±14.4: Z=4.15, p=0.003). Hyposalivation 
was observed more often in diabetic HD patients (Z=2.23, p=0.04). IGW was significantly higher in participants 
with diabetes (Z=2.44, p=0.03), as was the pre-dialysis sodium serum (Z=3.4, p=0.008). High levels of HbA1c 
were associated with lower levels of serum sodium (r=-0.67 p<0.05). HbA1c positively correlated with pre-di-
alysis sodium gradient (r=0.66 p<0.05). However, multiple regression analysis found that the only predictors of 
increased IWG (>4.8 IWG%) in diabetic patients remained saliva flow rate and pre-dialysis sodium gradient.
Conclusions: Concomitant diabetes in hemodialysis patients appears to intensify subjective xerostomia and thirst 
sensation. It also leads to excessive IWG by the increase of pre-dialysis serum sodium gradient.
Key words: Diabetes mellitus, hemodialysis, hyposalivation, inter-dialytic weight gain, sodium gradient.
doi:10.4317/medoral.22294
http://dx.doi.org/doi:10.4317/medoral.22294
Bruzda-Zwiech A, Szczepańska J, Zwiech R. Xerostomia, thirst, sodi-
um gradient and inter-dialytic weight gain in hemodialysis diabetic 
vs. non-diabetic patients. Med Oral Patol Oral Cir Bucal. 2018 Jul 1;23 
(4):e406-12.   
http://www.medicinaoral.com/medoralfree01/v23i4/medoralv23i4p405.pdf
Article Number: 22294          http://www.medicinaoral.com/
© Medicina Oral S. L. C.I.F. B 96689336 - pISSN 1698-4447 - eISSN: 1698-6946
eMail:  medicina@medicinaoral.com 
Indexed in: 
Science Citation Index Expanded
Journal Citation Reports
Index Medicus, MEDLINE, PubMed
Scopus, Embase and Emcare 
Indice Médico Español
Med Oral Patol Oral Cir Bucal. 2018 Jul 1;23 (4):e406-12.                                                                                    Xerostomia, sodium gradient and IWG in HD diabetic vs. non-diabetic patients  
e407
Introduction
According to the 2013 ERA-EDTA Registry annual 
report, diabetes is an important contributor to replace-
ment renal therapy (RRT) in Europe and the Mediter-
ranean. Patients with diabetes mellitus as the cause of 
ESRD comprised 24% of the incident RRT patients and 
17% of the prevalent RRT patients (1). 
Although great improvements have been noticed, pa-
tients with diabetes receiving RRT continue to have sig-
nificantly worse prognosis than non-diabetic patients, 
as well as a higher mortality rate, which is of cardiovas-
cular origin in the majority of cases (1,2,3). 
Both diabetes mellitus and renal diseases are condi-
tions that directly affect the salivary glands and may 
cause decreased salivary production (4,5). The preva-
lence of xerostomia, a subjective feeling of dry mouth, 
in hemodialysis patients ranges between 32.9 and 76.4% 
(6-8). It may be associated with objectively measured 
hyposalivation or with changes in the quality of saliva, 
with the amount of saliva itself remaining unchanged 
(9). In hemodialysis (HD) patients, xerostomia and hy-
posalivation lead to numerous oral sequelae (10), but 
may also intensify sensations of thirst, and contrib-
ute to the intake of fluids and excessive inter-dialytic 
weight gain (IWG);  this increased intake can lead to 
chronic fluid overload, resulting in cardiovascular com-
plications (6,11,12). Our previous studies found higher 
inter-dialysis weight gain in hemodialysis patients with 
hyposalivation than those with normosalivation, and a 
positive correlation between both xerostomia and thirst 
with IWG in HD patients; however, multivariable anal-
ysis found that pre-dialysis sodium gradient and low-
ered saliva flow rate remained significant predictors of 
excessive IWG. Despite this, the study did not address 
the hypothesis that xerostomia, hyposalivation or pre-
dialysis sodium gradient contributes to greater IWG in 
diabetic HD patients (8). 
Analysis of the United States Renal Data System 
(USRDS) Dialysis Morbidity and Mortality Waves 
3 and 4 Study showed that large inter-dialytic weight 
gains of more than 4.8% are associated with shorter 
survival when comorbidity is taken into account (13). 
Owing to the fact that some studies have demonstrated 
that IWG is higher in diabetic HD than in HD patients 
without concomitant diabetes (14-16) and that increased 
IWG is associated with a higher mortality in diabetic 
patients on maintenance hemodialysis (16), it is impor-
tant to define the underlying causes of increased IWG 
in diabetic HD patients to establish new therapeutic op-
tions. Although Sung et al. report that xerostomia and 
lowered serum sodium may be contributing factors to 
greater IGW in both diabetic and non-diabetic HD pa-
tients (14), no other previous studies have investigated 
whether thirst sensation or pre- and post-dialysis serum 
sodium gradients influence IWG in diabetic HD pa-
tients. The aim of the study was therefore to determine 
whether concomitant diabetes considerably influences 
unstimulated salivary flow rate, xerostomia, thirst sen-
sation, serum sodium gradient and IWG in hemodialy-
sis patients, and to investigate which of the mentioned 
parameters contribute to an increased IWG in diabetic 
HD patients.
Material and Methods 
-Study subjects
Study participants were recruited from a pool of 148 
patients who were undergoing maintenance hemodialy-
sis at the Dialysis Department of the Norbert Barlicki 
Memorial Teaching Hospital No. 1. The eligibility cri-
teria for a patient to be included onto the study were 
as follows: age between 18 and 80 years, a fixed he-
modialysis schedule of three times a week and a stable 
clinical condition. The exclusion criteria comprised un-
controlled hypertension or recurrent symptomatic hy-
potension episodes, chronic heart failure (NYHA stage 
4), severe acute infections requiring hospitalization and 
the administration of centrally-acting sympathicolytics. 
Finally, the study included 97 patients (55 male and 43 
female) receiving maintenance hemodialysis (mean age 
59.1 ± 13.6 years), including 38 patients with diabetes. 
The study was conducted in compliance with the prin-
ciples of the Helsinki Declaration. The study protocol 
was approved by the Medical University of Lodz Bio-
ethics Committee, Resolution Number RNN 147/09/
KE. Informed consent was obtained from all patients 
prior to their inclusion in the study. The mean time from 
starting hemodialysis was at least six months. The mean 
session time was 253 minutes. The causes of end-stage 
renal disease included chronic glomerulonephritis in 28 
patients, diabetic nephropathy in 26, adult polycystic 
kidney disease in eight, hypertension in 22, tubuloint-
erstitial nephritis in six and unknown in seven patients. 
All patients were advised to maintain their usual di-
etary habits.
Participants were divided into two subgroups: non-
diabetic HD patients and diabetic HD patients with a 
history of diabetes longer than six months (the mean 
diabetic history was 38.8 ± 21.4 months). Only insulin-
dependent patients participated in the study. The non-
diabetic HD and the diabetic HD groups were age and 
sex matched, and significant parameters including num-
ber of participants with preserved residual urination, 
and mean hemodialysis session time were comparable. 
The characteristics of the non-diabetic and diabetic HD 
patients are summarized in Table 1.
-Assessment of thirst intensity, xerostomia, UWSFR, 
IGW and sodium gradients   
All participants completed a survey evaluating thirst in-
tensity comprising the Dialysis Thirst Inventory (DTI) 
and Xerostomia Inventory (XI). The dialysis thirst in-
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 DM patients Non-DM  patients 
N 38 59 
Males 24 31 
Age (years) 57.5 ± 14.2 58.8 ± 12.5 
Catheters 6 8 
Xerogenic medication (n) 8 12 
Alcohol consumption 1 3 
Dentures (n) 15 23 
Hemodialysis vintage (months) 11.8 ± 6.1 13.2 ± 7.2 
Dialysis session time (minutes) 260 ± 20 250 ± 30 
Kt/V 1.22± 0.1 1.23 ± 0.2 
Hgb (g/dl) 
 
10.6± 1.1 11.0 ± 1.3 
Residual diuresis (n) 8 14 
Smokers (n) 7 12 




Table 1: Characteristics of the study population.
ventory is a questionnaire consisting of seven items, 
each with a five-point Likert scale ranging from never 
(1) to always (5). The results ranged from a minimum 
of seven points (no thirst) to a maximum 35 points 
(enormous thirst). The validated xerostomia inventory 
comprises 11 items, each with a 5-point Likert scale 
ranging from never (1) to always (5), with the results 
from 11 points (no dry mouth) to a maximum 55 points 
(extremely dry mouth). 
Unstimulated whole saliva flow rate was measured, with 
USWFR below 0.1 ml/min being regarded as evidence 
of hyposalivation (17). The unstimulated whole saliva 
was collected for five minutes by the spitting method 
before a mid-week HD session. The subject refrained 
from eating, tooth brushing, mouth rinsing or smoking 
for at least one hour before spitting. They were seated 
in an upright position and asked to relax during spitting. 
The details of the saliva collection method are described 
elsewhere (8). The saliva flow rate was then calculated 
in milliliters per minute. The survey and saliva samples 
were obtained under the supervision of an experienced 
dentist (the author) who was blinded to patients’ medi-
cal records. 
The results of biochemical tests, i.e. pre- and post-dial-
ysis serum sodium concentration and sodium gradient 
(the difference between serum sodium and dialysis fluid 
sodium concentration), are presented as absolute num-
bers. Hemoglobin A1c (HbA1c) was measured to assess 
glycemic control in HD diabetic patients. All measure-
ments were carried out routinely, as a part of every 
month HD patients’ assessment, in certified central hos-
pital laboratory automatic analyzers. At the same time, 
inter-dialytic weight gain (IWG), defined as the differ-
ence between current body mass and dry weight, was 
measured. All assessments, i.e. blood specimens, saliva 
collection and the survey, were conducted according 
to single time-point assessment during the mid-week 
HD session. The antihypertensive treatment allowed 
blood pressure below 140/90 mmHg before, and 130/80 
mmHg after hemodialysis to be achieved in most of the 
participants. In both subgroups, antihypertensive treat-
ment was not changed and doses were stable. The kid-
ney replacement therapy was conducted on Fresenius 
4008 dialysis machines exclusively. Standard bicarbon-
ate dialysate fluid containing 140 mmol/l of sodium, 
1.25 mmol/l of calcium and 0.75 mmol/l of magnesium 
was used. The potassium concentration varied depend-
ing on the degree of patient kalemia before the session. 
Dialysis adequacy was assessed, with a single pooled 
kT/V of average value 1.2 to 1.4 being regarded as ad-
equate. Dry weight was established based on clinical 
examination, blood pressure measurements and whole 
body composition spectroscopy (18). In all participants, 
the mineral bone disorder associated with renal anemia 
and kidney diseases was successfully treated according 
to KDOQI and KDIGO recommendations (19,20). The 
above-mentioned clinical procedures were performed 
by the staff of the Dialysis Department and supervised 
by the Head of Department (co-author).  
-Statistical analysis
The abnormality of the distribution was checked by the 
Kolmogorov-Smirnov test. Comparisons between the 
study subgroups were performed using the Mann-Whit-
ney test. The Fisher’s exact probability test was used 
for gender comparison. Correlations were assessed by 
Spearman’s rank correlation coefficient. Possible pre-
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dictors of excessive weight gain were analyzed by mul-
tiple regression coefficients. Differences were consid-
ered significant if the p-value was less than 0.05. The 
results were expressed as mean ± standard deviation 
and median (interquartile range). Statistical analysis 
was performed using Statistica for Windows software 
(version 10.0). Post hoc interim assessment for sample 
size re-estimation to asses the appropriate statistical 
Power test using G*Power (a free tool for test power 
assessment) was performed, which indicated statistical 
power of over 80 % (0.83).
Results
No differences were observed between the two study 
groups with regard to basic parameters. The character-
istics of the study population are presented in Table 1. 
Significantly higher scores were found in diabetic HD 
patients then non-diabetic patients with regard to DTI 
(21.2 ± 7.7 vs. 17.1 ± 6.2: Z=2.44, p=0.03) and xerosto-
mia (40.5 ± 6.1 vs. 29.9 ± 14.4: Z=4.15, p=0.003). Al-
though no significant difference was observed between 
non-diabetic HD and diabetic HD patients with regard 
to mean unstimulated salivary flow, hyposalivation 
(UWSFR<0.1 mL/min) was observed more often in dia-
betic HD patients  (Z=2.23, p=0.04). 
A statistically significant difference was seen between 
subgroups with regard to inter-dialysis weight gain, 
which was higher in participants with diabetes (Z=2.44, 
p=0.03). Neither pre- nor post-dialysis sodium serum 
concentration differed between study groups. Both HD 
patients with and without diabetes demonstrated simi-
lar post-dialysis sodium serum gradients. However, the 
 
 DM patients Non-DM  patients 
Pre-dialysis sodium serum 
concentration (mmol/l) 
137.0 ± 2.2 
137 (132-140) 
138.6 ± 2.7 
139 (134-141) 
Post-dialysis sodium serum 
concentration (mmol/l) 
138 ± 2.6 
138 (135-141) 
138.6 ± 2.4 
138 (136-141) 
Pre-dialysis sodium gradient 
 
3.08 ± 2.3 
3 (0-7) a 
1.5 ± 2.8 
2 (0-6) a 
Post-dialysis sodium gradient 
 
1.9 ± 2.3 
2 (0-5) 
1.5 ± 2.4 
2 (0-5) 
Thirst score (pts) 
 
21.2 ± 7.7 
22 (7-33) b 
17.1 ± 6.2 
17 (7-27) b 
Xerostomia score (pts) 
 
40.5 ± 6.1 
38 (30-53) c 
29.9 ± 14.4 
30 (14-48) c 
Hyposalivation (n) [%] 
 
Saliva flow rate (ml/min) 
15d [39%] 
 




0.36 ± 0.29 
0.36 (0-1.2) 
 
Inter-dialysis weight gain (kg) 
 
3.7 ± 1.9 
3.7 (1.9-8.8) e 
2.8 ± 1.2 
3 (1.1-4.1) e 
 
Table 2: The comparison of parameters in HD patients with (DM patients) and without diabetes mellitus (Non-
DM patients). 
aZ=3.4, p=0.008; bZ=2.44, p=0.03; cZ=4.15, p=0.003; dZ=2.23, p=0.04; eZ=2.88, p=0.007.
pre-dialysis sodium serum gradient was significantly 
higher in the group with diabetes (Z=3.4, p=0.008). Ta-
ble 2 presents the comparison of described parameters 
in HD patients with and without diabetes. In all DM-
patients, hemoglobin A1c (HbA1c) level was measured 
to assess glycemic control. Its mean value was stable 
at 6.5 ± 0.4 %. Higher levels of HbA1c were associated 
with lower levels of serum sodium (r= -0.67 p<0.05). 
HbA1c level positively correlated with pre-dialysis so-
dium serum gradient (r=0.66 p<0.05). Table 3 shows the 
results of multiple regression of predictors (coefficients) 
of excessive weight gain (>4.8 IWG%) in DM hemodi-
alysis patients. The only predictors of increased IWG in 
diabetic patients were saliva flow rate and pre-dialysis 
sodium gradient. 
Discussion
The results of our study confirm that xerostomia is 
more severe in hemodialysis patients with insulin-
dependent diabetes when assessed using the Xerosto-
mia Inventory. This was also noted by Chuang et al. 
(20,21) and Sung et al. (14), who evaluated the severity 
of dry mouth sensation in HD patients with or without 
diabetes using a visual analog scale (VAS). In addition, 
Swapna et al. report that xerostomia is more common in 
HD patients suffering from diabetes - 62% of non-suf-
ferers vs. 78.7% of sufferers (22). In contrast to Sung at 
al. (14), our findings do not indicate any significant dif-
ferences in UWSFR between diabetic and non-diabetic 
HD patients. This could be explained by the fact that 
in ERDS patients on maintenance hemodialysis, uremic 
involvement of salivary glands and dehydration from 
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Table 3: Multiple regression of predictors (coefficients) of excessive weight gain (>4.8 IWGD%) in diabetic hemodialysis patients.
HbA1c – glycolysated hemoglobin.
restricted fluid intake can lead to decreased salivary 
flow. However, hyposalivation (USWFR below 0.1 ml/
min) was observed more often in diabetic HD patients, 
probably due to the synergic effect of diabetes and ure-
mic changes in salivary glands. Also, Vesterinen et al. 
found no differences in USWFR in cases of diabetic and 
non-diabetic chronic kidney disease at the predialysis 
stage (0.4±0.9 ml/min vs. 0.2±0.9 ml/min); however, 
stimulated salivary flow was significantly lowered in 
the diabetic group (23). In contrast, Teratani et al. re-
port no statistically significant differences in stimulated 
salivary flow in patients undergoing HD for diabetic ne-
phropathy or chronic glomerulonephritis, although the 
saliva flow rate was significantly lower in both groups 
of HD patients than in the control group (24). Our find-
ings confirm that inter-dialytic weight gains are higher 
in diabetic HD patients than those without concomitant 
diabetes, which is in line with previous studies (14-16). 
One of predictors of increased IWG in diabetic HD 
patient was lowered saliva flow (UWSFR). In addi-
tion, Sung et al. who examined the interaction between 
UWSFR and IGW in study group numerically similar 
to ours -51 non-diabetic and 40 diabetic HD patients, 
note that UWSFR was negatively correlated with IWG 
in diabetic and non-diabetic HD patients (14).  
However, in contrast to Sung et al. (14), who found oral 
dryness score to be associated with IWG in both non-
diabetic and diabetic HD patients, the only predictor in 
diabetic HD patients in the present study was found to 
be pre-dialysis sodium gradient. In addition, our find-
ings show that diabetic HD patients with higher levels 
of HbA1c had lower serum sodium levels and higher 
pre-dialysis sodium gradients, and Creame and Mc Caf-
fery report a negative correlation between poor glyce-
mic control and pre-dialysis sodium (25). Those find-
ings seem to provide a new insight into the mechanisms 
behind excessive IGW in diabetic patients. 
IWG is the product of accumulation of water in the body 
from the metabolism and by dietary and fluid intake. 
The major mechanism leading to excessive IWG in HD 
patients seems to be the osmoregulation pathway (cit. 14). 
In our study, diabetic HD patients were found to have a 
higher thirst score. Thirst is induced when osmorecep-
tors are stimulated by high plasma osmolality. However, 
Thompson et al. found hypertonic D-glucose infusion 
to cause similar elevations in blood glucose in diabetic 
patients and healthy controls, but did not change plasma 
vasopressin or thirst ratings; in contrast, infusion of hy-
pertonic sodium chloride was accompanied by progressive 
increases in plasma vasopressin in both diabetic and non-
diabetic patients, implying that hyperglycemia per se is not 
a direct stimulus of thirst in diabetic patients (26).
Not complying with salt restriction, followed by exces-
sive water intake, is believed to be one of the key causes 
of increased IWG in hemodialysis patients. To maintain 
stable osmolality under physiological conditions, exces-
sive sodium urine excretion is triggered. However, this 
mechanism is insufficient in HD diabetic patients, even 
those with residual diuresis, and fluid intake is the only 
mechanism that can restore normal osmolality. Since 
water cannot be effectively excreted in HD patients, 
excess fluid intake causes hypo-osmolality, which in 
turn increases salt appetite and sodium intake. There-
fore, HD patients not complying with salt restriction 
might demonstrate greater IGW without hyponatremia, 
whereas patients complying with salt restriction by di-
lutional effect due to excessive water intake might have 
greater IWG with hyponatremia, due to the dilutional 
effect caused by excessive water intake (cit. 14). Hence, 
the presence of a lower serum sodium concentration in 
diabetic HD patients than non-diabetic HD patients, 
observed in our present study, may suggest that the 
greater IGW found in these groups of patients was not 
only due to more salt consumption, which is a natural 
thirst stimulus, but that other stimuli were involved. 
Therefore, patients with high inter-dialytic weight gain 
and low predialysis sodium should be assessed for other 
reasons for fluid intake, such as high blood glucose or 
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social drinking (27). Hyperglycemia increases extra-
cellular fluid osmolality and causes an osmotic shift of 
water and potassium from the intracellular to the ex-
tracellular fluid (2). Water translocation induced by el-
evated serum glucose level results in a relative decrease 
in serum sodium concentration, i.e. translocational hy-
ponatremia (28). Synergic effect of hyperglycemia and 
non-effective sodium elimination probably provoke 
thirst, as fluid intake is the only mechanism by which 
normal osmolality can be restored. It could also explain 
the significantly higher thirst score in diabetic HD pa-
tients than non-diabeticpatients observed in our study. 
In diabetic HD patients, excessive fluid intake leads 
to fluid overload, resulting in lowered serum sodium 
and increased pre-dialysis sodium gradient. As noted 
in our previous study, increased pre-dialysis sodium 
gradients might be a contributory factor to increased 
IWG in HD patients. The described mechanism seems 
to create a ‘vicious circle’ effect, which is most clearly 
observed in diabetic patients. The presence of elevated 
IWG caused by increased fluid gains implicates a higher 
ultrafiltration rate during hemodialysis session. Never-
theless, rapid body fluid shifts, mainly in the extracellu-
lar intravascular compartment, results in intra-dialysis 
hypotension. In diabetes patients, deregulation of the 
autonomic nervous system caused by ERDS (uremia) 
is further aggravated by diabetic neuropathy, resulting 
in intra-dialysis hypotension (29). This results in a fail-
ure to maintain an adequate ultrafiltration rate and to 
achieve an ideal dry body mass, leading to persistent 
fluid overload and a lowering of serum sodium in dia-
betic HD patients. Good glycemic control is therefore 
of great importance in diabetic HD patients, as studies 
of Hwang et al. (29), Mandai et al. (30), Perez-Garcia 
(31) demonstrate that lower serum sodium is an inde-
pendent predictor of a higher risk infection-related hos-
pitalization, and is associated with a high prevalence of 
comorbidities and long-term mortality risk in patients 
on maintenance hemodialysis.
In conclusion, concomitant diabetes in hemodialysis 
patients appears to intensify subjective xerostomia and 
thirst sensation. It also leads to excessive inter-dialytic 
weight gain by the increase of pre-dialysis serum so-
dium gradients.
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